Revlimid and disease progression 
Revlimid and disease progression Patient Reports February 11, 2012
Revlimid Side Effects Report #5305170-9
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Apr 09, 2007. Male patient, 78 years of age, was diagnosed with thyroid cancer
and was treated with Revlimid. After drug was administered, patient experienced the following side effects: abasia, asthenia, disease progression, ocular hyperaemia, red blood cell count decreased. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient recovered.Revlimid Side Effects Report #5324947-7
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 30, 2007. Male patient, 78 years of age, was diagnosed with thyroid cancer
and was treated with Revlimid. After drug was administered, patient experienced the following side effects: abasia, asthenia, cardiac failure, disease progression, ocular hyperaemia, performance status decreased, red blood cell count decreased. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, NEXIUM, ALTACE, FLOMAX, METFORMIN, TOPROL, LASIX. Patient died on 04/11/2007.Revlimid Side Effects Report #5874946-1
Revlimid side effect was reported by a Consumer or non-health professional from FRANCE on Sept 02, 2008. Female patient, weighting 125.7 lb, was diagnosed with t-cell lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bradycardia, disease progression, respiratory arrest. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 08/29/2008.
Revlimid Side Effects Report #5884569-6
Revlimid side effect was reported by a Consumer or non-health professional from FRANCE on Sept 11, 2008. Female patient, weighting 125.7 lb, was diagnosed with t-cell lymphoma, cough, antibiotic prophylaxis, haematotoxicity, cytomegalovirus chorioretinitis, increased bronchial secretion, rhinitis, anxiety
and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bradycardia, cardiac arrest , disease progression. Revlimid dosage: unknown. During the same period patient was treated with CODEINE SUL, BACTRIM, LEDERFOLINE, ROVALCYTE, DINACODE, POLARAMINE, ATARAX. Patient was hospitalized. Patient died on 08/29/2008.Revlimid Side Effects Report #5463800-5
Revlimid side effect was reported by a Health Professional from UNITED STATES on Sept 12, 2007. Male patient, 85 years of age, was diagnosed with sarcoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: arthralgia, atelectasis, cellulitis
, deep vein thrombosis , disease progression, erythema, fatigue, haematocrit decreased, haemoglobin decreased. Revlimid dosage: 20 MG, QD X14 DAYS, ORAL. During the same period patient was treated with DOCETAXEL, IMDUR, GLIPIZIDE, VICODIN, MIRALAX, FLOMAX, VITAMIN B6, FOLIC ACID. Patient was hospitalized. Patient died on 09/09/2007.Revlimid Side Effects Report #5525351-9
Revlimid side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Male patient, 85 years of age, was diagnosed with sarcoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: arthralgia, atelectasis, cellulitis
, deep vein thrombosis , disease progression, fatigue, haematocrit decreased, haemoglobin decreased, insomnia. Revlimid dosage: 20 MG, QD X14 DAYS, ORAL. During the same period patient was treated with DOCETAXEL, IMDUR, GLIPIZIDE, VICODIN, MIRALAX, FLOMAX, VITAMIN B6, FOLIC ACID. Patient was hospitalized. Patient died on 09/09/2007.Revlimid Side Effects Report #5981583-7
Revlimid side effect was reported by a Physician from GERMANY on Nov 24, 2008. Male patient, weighting 149.9 lb, was diagnosed with rosai-dorfman syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5194106-X
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 18, 2006. Male patient, 84 years of age, was diagnosed with refractory anaemia and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, platelet count decreased, refractory anaemia. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with XALATAN, MEGACE, PROTONIX, LEVOXYL, DIOVAN, CARDURA, DETROL LA. Patient died on 11/01/2006.
Revlimid Side Effects Report #5007444-8
Revlimid side effect was reported by a Health Professional from UNITED STATES on May 19, 2006. Male patient, weighting 147.0 lb, was diagnosed with prostate cancer
and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, prostate cancer . Revlimid dosage: 10 MG QD PO. During the same period patient was treated with PREDNISONE, LUPRON, COLACE, ASPIRIN, TYLENOL, CENTRUM, FENTANYL. Patient died on 05/17/2006.Revlimid Side Effects Report #5834798-2
Revlimid side effect was reported by a Consumer or non-health professional from GERMANY on July 23, 2008. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with plasmacytoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: bronchitis
, coordination abnormal, disease progression, hyperhidrosis, left atrial dilatation, multiple myeloma , parkinsonism, plasmacytoma, tremor. Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.Revlimid Side Effects Report #5352254-5
Revlimid side effect was reported by a Physician from UNITED STATES on May 30, 2007. Male patient, 55 years of age, was diagnosed with plasmablastic lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, mental status changes, renal failure acute. Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COMBIVIR, VIRAMUNE, OMEPRAZOLE, EFFEXOR, LYRICA, PROPRANOLOL. Patient died on 03/16/2007.
Revlimid Side Effects Report #5832131-3
Revlimid side effect was reported by a Physician from UNITED STATES on July 21, 2008. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fall
, hip fracture, rash , red blood cell count decreased. Revlimid dosage: 10MG - 25MG, QD, ORAL, 20 MG, X21 DAYS EVERY 28 DAYS, ORAL. Patient was hospitalized. Patient died on 02/07/2008.Revlimid Side Effects Report #5641799-6
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 04, 2007. Male patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, renal failure. Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5162613-1
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Nov 15, 2006. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fluid overload, leukopenia, malignant neoplasm progression, metastases to lung, neutropenia, pleural effusion, pseudomonal sepsis, sarcoma. Revlimid dosage: 10 MG, DAILY DURING 21 DAYS CYCLE, ORAL. During the same period patient was treated with AVASTIN, TOPOTECAN, NEUPOGEN. Patient was hospitalized. Patient died on 05/26/2006.
Revlimid Side Effects Report #5843062-7
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 05, 2008. Male patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, loss of consciousness, non-hodgkin's lymphoma, renal failure. Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 06/28/2008.
Revlimid Side Effects Report #5205180-6
Revlimid side effect was reported by a Physician from CANADA on Jan 03, 2007. Male patient, 48 years of age, weighting 162.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, band neutrophil count decreased, disease progression, lymphoma
, oedema peripheral, pitting oedema, thrombocytopenia, white blood cell count decreased. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 12/14/2006.Revlimid Side Effects Report #5261720-2
Revlimid side effect was reported by a Physician from CANADA on Feb 28, 2007. Male patient, 48 years of age, weighting 162.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, lymphoma
, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 12/14/2006.Revlimid Side Effects Report #5848122-2
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Aug 14, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: constipation
, diarrhoea, disease progression, fatigue, neutropenia. Revlimid dosage: 25MG DAILY 21D/28D ORAL. During the same period patient was treated with ASPIRIN, ISORDIL, NITROGLYCERIN, ATENOLOL, LISINOPRIL, FAMOTADINE, FINASTERIDE, TEMAZEPAM. Patient recovered.Revlimid Side Effects Report #5869713-9
Revlimid side effect was reported by a Consumer or non-health professional from SPAIN on Sept 03, 2008. Male patient, weighting 188.5 lb, was diagnosed with non-hodgkin's lymphoma, anaemia, hypomagnesaemia, thrombosis prophylaxis, anxiety
and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, pancytopenia, pneumonia , pyrexia. Revlimid dosage: unknown. During the same period patient was treated with EPOETIN BETA, MAGNESIUM HYDROXIDE, MAGNESIUM LACTATE, ACETYLSALICYLIC ACID SRT, ENOXAPARIN, OMEPRAZOLE, LORAZEPAM. Patient was hospitalized. Patient died on 07/17/2007.Revlimid Side Effects Report #6082884-7
Revlimid side effect was reported by a Consumer or non-health professional from BELGIUM on Feb 13, 2009. Female patient, weighting 158.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: unknown. During the same period patient was treated with MAXIPIM, CASPOFUNGIN, LEDERTREXATE, BISOPROLOL, SIPRALEXA, OMEPRAZOLE, SPIRONOLACTONE. Patient died on 11/01/2008.
Revlimid Side Effects Report #5251977-6
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 13, 2007. Male patient, 62 years of age, was diagnosed with neoplasm and was treated with Revlimid. After drug was administered, patient experienced the following side effects: coronary artery disease
, disease progression, myelodysplastic syndrome, myeloproliferative disorder, myocardial infarction, renal failure. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/22/2007.Revlimid Side Effects Report #5371478-4
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Female patient was diagnosed with neoplasm and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, electrolyte imbalance, neutropenia, thrombocytopenia. Revlimid dosage: unknown. During the same period patient was treated with DOCETAXEL, CARBOPLATIN. Patient recovered.
Revlimid Side Effects Report #5647345-5
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 31, 2007. Male patient was diagnosed with neoplasm and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5089727-9
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 16, 2006. Male patient, 77 years of age, was diagnosed with myeloproliferative disorder and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia. Revlimid dosage: 5 MG, DAILY, ORAL. Patient died on 06/09/2006.
Revlimid Side Effects Report #5938416-4
Revlimid side effect was reported by a Consumer or non-health professional from SPAIN on Oct 21, 2008. Female patient was diagnosed with myeloma recurrence, platelet aggregation inhibition and was treated with Revlimid. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, disease progression, neutropenia, pyrexia, thrombocytopenia. Revlimid dosage: 15/10MG IN CASE OF RENAL FAILURE. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, ENOXAPARIN. Patient died.Revlimid Side Effects Report #5213927-8
Revlimid side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 81 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/16/2006.
Revlimid Side Effects Report #5671680-8
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 5 MG, 1 IN D, ORAL. Patient died on 02/04/2008.
Revlimid Side Effects Report #5571116-1
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 13, 2007. Male patient, 78 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL; 10 MG, IN 1 IN D, ORAL. Patient died on 11/09/2007.
Revlimid Side Effects Report #5705500-X
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 04, 2008. Male patient, 77 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis, myeloid metaplasia. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2008.
Revlimid Side Effects Report #5061094-6
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 74 years of age, was diagnosed with myelofibrosis, myeloid metaplasia and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, neutropenia, thrombocytopenia. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. During the same period patient was treated with PREDNISONE, ADVAIR DISKUS, COMBIVENT, IPRATROPIUM BROMIDE, SOLTALOL, FOLIC ACID, OMEPRASONE. Patient died on 05/22/2006.
Revlimid Side Effects Report #5043875-8
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Male patient, 74 years of age, was diagnosed with myelofibrosis, myeloid metaplasia and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, neutropenia, thrombocytopenia. Revlimid dosage: unknown. During the same period patient was treated with PREDNISONE, ADVAIR DISKUS, COMBIVENT. Patient died on 05/22/2006.
Revlimid Side Effects Report #5270605-7
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 09, 2007. Male patient, 72 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 5 MG, QOD, ORAL. Patient was hospitalized. Patient died.
Revlimid Side Effects Report #5289505-1
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 21, 2007. Male patient, 71 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, no therapeutic response, pancytopenia. Revlimid dosage: unknown. Patient died on 02/13/2007.
Revlimid Side Effects Report #5141695-7
Revlimid side effect was reported by a Health Professional from UNITED STATES on Oct 16, 2006. Male patient, 70 years of age, was diagnosed with myelofibrosis, myeloid metaplasia, myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cellulitis
, cerebrovascular accident, diarrhoea, disease progression, leukaemia, localised infection, osteomyelitis, pancytopenia, pericardial effusion. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with THALOMID, PROCRIT, ATENOLOL, CARDURA, MIRALAX, XANAX, GLUCOPHAGE. Patient was hospitalized. Patient recovered.Revlimid Side Effects Report #5705177-3
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 03, 2008. Male patient, 70 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: coronary artery stenosis, disease progression, hypertension, myelodysplastic syndrome, myelofibrosis, pancytopenia, pneumonia
, pseudomonal sepsis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/14/2007.Revlimid Side Effects Report #5706381-0
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 03, 2008. Male patient, 70 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: 5q-syndrome, coronary artery stenosis, disease progression, hypertension, myelodysplastic syndrome, myelofibrosis, pneumonia
, pseudomonal sepsis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/14/2007.Revlimid Side Effects Report #5213918-7
Revlimid side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 69 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5232629-5
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 29, 2007. Male patient, 69 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis, pancytopenia. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with LANTUS, ISOSORBIDE, METOPROLOL TARTRATE, LASIX, RESTORIL, DIOVAN, MORPHINE SULPHATE. Patient died.
Revlimid Side Effects Report #5261924-9
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Male patient, 68 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2007.
Revlimid Side Effects Report #5453517-5
Revlimid side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Male patient, 68 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2007.
Revlimid Side Effects Report #5483612-6
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Female patient, 63 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 03/26/2007.
Revlimid Side Effects Report #5797778-1
Revlimid side effect was reported by a Physician from UNITED STATES on June 23, 2008. Male patient, 55 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5831499-1
Revlimid side effect was reported by a Physician from UNITED STATES on July 21, 2008. Male patient, 55 years of age, weighting 222.8 lb, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: bone marrow failure, constipation
, disease progression, fatigue, iron overload, renal impairment. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ADVIL, CLARITIN, TRANSFUSION. Patient died.Revlimid Side Effects Report #5635795-2
Revlimid side effect was reported by a Health Professional from SPAIN on Feb 15, 2008. Male patient was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 5 MG,DAILY,ORAL. Patient died.
Revlimid Side Effects Report #6056181-X
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Jan 23, 2009. Male patient was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anorexia, asthenia, atrial fibrillation
, chest pain , cough, disease progression, dyspnoea, fatigue. Revlimid dosage: 10MG DAILY ORALLY. During the same period patient was treated with AVELOX, ALBUTEROL, SIMVASTATIN, BACTRIM DS, HYDROXYUREA, NOVOLIN N, METFORMIN. Patient was hospitalized. Patient died on 01/10/2009.Revlimid Side Effects Report #5145553-3
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 25, 2006. Male patient, 96 years of age, was diagnosed with myelodysplastic syndrome, multiple myeloma
and was treated with Revlimid. After drug was administered, patient experienced the following side effects: blood erythropoietin increased, disease progression, myelodysplastic syndrome, prothrombin time prolonged, pulmonary embolism , serum ferritin increased. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with THALOMID, COUMADIN. Patient died on 05/26/2006.Revlimid Side Effects Report #5140201-0
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 19, 2006. Male patient, 95 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 01/01/2006.
Revlimid Side Effects Report #5164128-3
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 15, 2006. Male patient, 95 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, dysphonia, dyspnoea, fatigue, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VITAMIN, PROTONIX, DIGOXIN, ASPIRIN, FOLIC ACID, POTASSIUM, LASIX. Patient was hospitalized. Patient died on 10/11/2006.
Revlimid Side Effects Report #5472190-3
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 20, 2007. Male patient, 91 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.
Revlimid Side Effects Report #5067887-3
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2006. Female patient, 90 years of age, was diagnosed with myelodysplastic syndrome, refractory anaemia with an excess of blasts, waldenstrom's macroglobulinaemia and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, refractory anaemia with an excess of blasts, waldenstrom's macroglobulinaemia. Revlimid dosage: unknown. Patient died on 06/10/2006.
Revlimid Side Effects Report #5463805-4
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, renal failure chronic. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, ARANESP, COREG, LASIX. Patient was hospitalized. Patient died on 07/13/2007.
Revlimid Side Effects Report #5489240-0
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 10, 2007. Male patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, myelodysplastic syndrome, platelet count decreased. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, ARANESP, COREG, LASIX. Patient was hospitalized. Patient died on 07/13/2007.
Revlimid Side Effects Report #5502784-8
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 23, 2007. Male patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, myelodysplastic syndrome, platelet count decreased, renal failure chronic. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, ARANESP, COREG, LASIX. Patient was hospitalized. Patient died on 07/13/2007.
Revlimid Side Effects Report #5525045-X
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 13, 2007. Female patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.
Revlimid Side Effects Report #5566878-3
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 11, 2007. Male patient, 89 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL, 5-10 MG, ORAL. Patient was hospitalized. Patient died on 09/01/2007.
Revlimid Side Effects Report #4943358-7
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Mar 03, 2006. Female patient, 89 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: blast cell count increased, disease progression, fatigue. Revlimid dosage: 10 MG, DAILY, ORAL. Patient died on 02/07/2006.
Revlimid Side Effects Report #5378035-4
Revlimid side effect was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, 88 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, myocardial infarction. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 03/19/2007.
Revlimid Side Effects Report #5391048-1
Revlimid side effect was reported by a Physician from UNITED STATES on July 11, 2007. Male patient, 88 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. Patient died on 05/02/2007.
Revlimid Side Effects Report #5821534-9
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2008. Female patient, 88 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 06/01/2008.
Revlimid Side Effects Report #5242064-1
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 01, 2007. Female patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 09/21/2006.
Revlimid Side Effects Report #5242529-2
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Feb 02, 2007. Female patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, thrombocytopenia. Revlimid dosage: unknown. Patient died.
Revlimid Side Effects Report #5141693-3
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome, refractory anaemia with an excess of blasts and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with MONOPRIL, PLAVIX, SYNTHROID, LANOXIN. Patient died on 07/04/2006.
Revlimid Side Effects Report #5479075-7
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 27, 2007. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, physical examination abnormal, thrombocytopenia. Revlimid dosage: 5 MG, 1 IN 2 D, ORAL. Patient died on 09/11/2007.
Revlimid Side Effects Report #5484509-8
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 28, 2007. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, disease progression, no therapeutic response, physical examination abnormal, thrombocytopenia. Revlimid dosage: 5 MG, 1 IN 2 D, ORAL. Patient died on 09/11/2007.
Revlimid Side Effects Report #5639559-5
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2007. Female patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5165850-5
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2006. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 10/21/2006.
Revlimid Side Effects Report #5388768-1
Revlimid side effect was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, failure to thrive, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/23/2006.
Revlimid Side Effects Report #5712508-7
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 10, 2008. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia. Revlimid dosage: unknown. Patient died on 04/06/2008.
Revlimid Side Effects Report #5722747-7
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 15, 2008. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia. Revlimid dosage: unknown. Patient died on 04/06/2008.
Revlimid Side Effects Report #5748572-9
Revlimid side effect was reported by a Physician from UNITED STATES on May 14, 2008. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia, myelodysplastic syndrome, pancytopenia. Revlimid dosage: 5 MG, EVERY OTHER DAY, ORAL. Patient died.
Revlimid Side Effects Report #5218799-3
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 17, 2007. Female patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/18/2006.
Revlimid Side Effects Report #5266930-6
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 06, 2007. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, white blood cell count decreased. Revlimid dosage: unknown. Patient died on 01/01/2007.
Revlimid Side Effects Report #5195959-1
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Dec 20, 2006. Female patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/18/2006.
Revlimid Side Effects Report #5565785-X
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 07, 2007. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.
Revlimid Side Effects Report #5610342-X
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 23, 2008. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.
Revlimid Side Effects Report #5625328-9
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.
Revlimid Side Effects Report #5229312-9
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: decreased appetite, diarrhoea, disease progression, myelodysplastic syndrome, nausea
, pneumonia aspiration, stomach discomfort. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COUMADIN, ALLOPURINOL, COREG, VITAMIN B12, DIGOXIN, PROCRIT, LASIX. Patient was hospitalized. Patient died on 11/28/2006.Revlimid Side Effects Report #5232036-5
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 29, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5255175-1
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 20, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: chest pain
, disease progression, dyspnoea, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/29/2007.Revlimid Side Effects Report #5277952-3
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 13, 2007. Female patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: abdominal pain lower, deep vein thrombosis
, disease progression, myelodysplastic syndrome, pain in extremity, pleuritic pain, pyrexia, splenic infarction. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with AZACTIDINE. Patient was hospitalized. Patient died on 12/09/2006.Revlimid Side Effects Report #5701638-1
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Female patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, DAILY X21 DAYS, ORAL. Patient died.
Revlimid Side Effects Report #5840394-3
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Female patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL; 5-10 MG, DAILY, ORAL. Patient died.
Revlimid Side Effects Report #4989688-4
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 21, 2006. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, no adverse effect. Revlimid dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5242578-4
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Female patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, myelodysplastic syndrome, renal failure. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. Patient was hospitalized. Patient died on 06/01/2006.
Revlimid Side Effects Report #5348951-8
Revlimid side effect was reported by a Physician from UNITED STATES on May 29, 2007. Female patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, gastrointestinal haemorrhage, myelodysplastic syndrome, pancytopenia, renal failure, vomiting. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. During the same period patient was treated with ARANESP, SYNTHROID, TOPROL, FOLIC ACID, VITAMIN B, NEUMEGA. Patient was hospitalized. Patient died on 06/01/2006.
Revlimid Side Effects Report #5063643-0
Revlimid side effect was reported by a Physician from UNITED STATES on July 05, 2006. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, anaemia, disease progression, disseminated intravascular coagulation, myelodysplastic syndrome, pancytopenia, pneumonia
, renal failure, sepsis . Revlimid dosage: unknown. Patient died on 06/25/2006.Revlimid Side Effects Report #5471207-X
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 20, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome, myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelofibrosis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 08/01/2007.
Revlimid Side Effects Report #5472253-2
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 21, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 02/24/2007.
Revlimid Side Effects Report #5028140-7
Revlimid side effect was reported by a Physician from UNITED STATES on June 02, 2006. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 5 MG, QD, ORAL. Patient died on 03/14/2006.
Revlimid Side Effects Report #5337539-0
Revlimid side effect was reported by a Physician from UNITED STATES on May 18, 2007. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, haematochezia, haematocrit decreased, neutropenia, thrombocytopenia, white blood cell count decreased. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 12/19/2006.
Revlimid Side Effects Report #5337608-5
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fatigue, joint swelling, myelodysplastic syndrome, somnolence. Revlimid dosage: 10 MG, QD X28 DAYS, ORAL. During the same period patient was treated with PRILOSEC, CENTRUM SILVER, EXJADE. Patient died on 03/12/2007.
Revlimid Side Effects Report #5354445-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 05, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression. Revlimid dosage: 2.5 MG, 1 IN 2 D, ORAL. Patient died.
Revlimid Side Effects Report #5056575-5
Revlimid side effect was reported by a Physician from UNITED STATES on July 05, 2006. Female patient, 82 years of age, weighting 165.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, asthenia, diarrhoea, disease progression, dyspnoea, full blood count decreased, infection
, insomnia. Revlimid dosage: unknown. During the same period patient was treated with ATENOLOL, ZOLOFT, AMBIEN, IRON. Patient was hospitalized. Patient died on 01/01/2006.Revlimid Side Effects Report #5453498-4
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 06, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, myelodysplastic syndrome, rash
, swelling face. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 06/22/2007.Revlimid Side Effects Report #5467642-6
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fatigue, joint swelling, myelodysplastic syndrome, somnolence. Revlimid dosage: 10 MG, QD X 28 DAYS, ORAL. During the same period patient was treated with PRILOSEC, CENTRUM SILVER, EXJADE. Patient died on 03/12/2007.
Revlimid Side Effects Report #5483617-5
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, myelodysplastic syndrome, rash
, swelling face. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/22/2007.Revlimid Side Effects Report #5538303-X
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 29, 2007. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 05/31/2007.
Revlimid Side Effects Report #5639400-0
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 15, 2008. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/10/2008.
Revlimid Side Effects Report #5643792-6
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/08/2008.
Revlimid Side Effects Report #5713768-9
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 14, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome, refractory anaemia with an excess of blasts and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/26/2008.
Revlimid Side Effects Report #5786846-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 16, 2008. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD; ORAL. Patient died on 12/22/2007.
Revlimid Side Effects Report #5799183-0
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD X 21 DAYS Q 28 DAYS, ORAL. Patient died on 03/10/2008.